| CCC | I411 |
HepG2-Luc cell line is a specific cell line that has been genetically modified to express luciferase, a bioluminescent reporter enzyme. The HepG2 cell line itself is derived from human hepatocellular carcinoma (liver cancer) and has been widely used in cancer research and drug development. By introducing the luciferase reporter gene into HepG2 cells, researchers can monitor tumor growth, metastasis, and response to treatments using bioluminescence imaging techniques.
The development of the HepG2-Luc cell line has provided a valuable tool for studying liver cancer biology, tumor progression, and response to various therapeutic interventions. The ability to track tumor growth in real-time using bioluminescence imaging facilitates longitudinal studies and allows for precise evaluation of treatment outcomes in preclinical models.
Organism species: Homo sapiens (Human)
| CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
| Cells | CSI411Hu12 | Human Luciferase HepG2 Hepatocellular Carcinoma Cells (HepG2-Luc) | For research use only. It is not approved for human or animal use, or for applications in in vitro diganostic procedures. |
| Extracts | n/a | Extract of Luciferase HepG2 Hepatocellular Carcinoma Cells (HepG2-Luc) | Total Protein/DNA/RNA Extract Customized Service Offer |
| Mediums | MSI411Hu12 | Medium for Human Luciferase HepG2 Hepatocellular Carcinoma Cells (HepG2-Luc) | Complete Medium for the culture of HepG2-GFP-LUC cell line |